Inventor · disambiguated record
Dineli Wickramasinghe
Also filed as: WICKRAMASINGHE DINELI · WICKRAMASINGHE DINELI M
9 granted patents·10 pending applications·78 citations·filing 1999–2024
87Inventor score
Top patents by PatentIndex Score
19 records- 0194US9765157B2Antibody constructs for CDH19 and CD3AMGEN INC·Filed 2015·Granted Sep 19, 2017·13 cites·14 claims
- 0293US7615529B2Methods and compositions for modulating hyperstabilized c-metGENENTECH INC·Filed 2006·Granted Nov 10, 2009·35 cites·7 claims
- 0387US10059766B2Antibody constructs for CDH19 and CD3AMGEN RES MUNICH GMBH·Filed 2014·Granted Aug 28, 2018·9 cites·17 claims
- 0483US8536118B2Methods and compositions for modulating hyperstabilized c-metKONG-BELTRAN MONICA·Filed 2009·Granted Sep 17, 2013·16 cites·10 claims
- 0582US12297292B2Antibody constructs for CDH19 and CD3AMGEN INC·Filed 2017·Granted May 13, 2025·2 cites·12 claims
- 0681US11053311B2Antibodies targeting CDH19 for melanomaAMGEN INC·Filed 2018·Granted Jul 6, 2021·1 cites·25 claims
- 0781US2025084160A1Antibodies targeting cdh19 for melanomaAMGEN INC·Filed 2024·Application pending·0 cites
- 0879US11498964B2Antibody constructs for CDH19 and CD3AMGEN RES MUNICH GMBH·Filed 2018·Granted Nov 15, 2022·1 cites·17 claims
- 0978US12441796B2Antibody constructs for CDH19 and CD3AMGEN INC·Filed 2022·Granted Oct 14, 2025·0 cites·17 claims
- 1070US9920121B2Antibodies targeting CDH19 for melanomaAMGEN INC·Filed 2014·Granted Mar 20, 2018·1 cites·25 claims
- 1170US2022127354A1Antibodies targeting cdh19 for melanomaAMGEN INC·Filed 2021·Application pending·0 cites
- 1263US2010016241A1Methods and compositions for inhibiting c-met dimerization and activationGENENTECH INC·Filed 2009·Application pending·0 cites
- 1362US2020071405A1Antibody constructs for cdh19 and cd3AMGEN RES MUNICH GMBH·Filed 2019·Application pending·0 cites
- 1455US2005233960A1Methods and compositions for inhibiting c-met dimerization and activationGENENTECH INC·Filed 2004·Application pending·0 cites
- 1555US2007098707A1Methods and Compositions for Inhibiting C-MET Dimerization and ActivationGENENTECH INC·Filed 2006·Application pending·0 cites
- 1649US2012171210A1Methods and compositions for inhibiting c-met dimerization and activationKONG-BELTRAN MONICA·Filed 2012·Application pending·0 cites
- 1744US2003219427A1TPL-2/COT kinase and methods of useFiled 2003·Application pending·0 cites
- 1840US2008305106A1Novel Gene Disruptions, Composition and Methods Relating TheretoBRENNAN JANE·Filed 2005·Application pending·0 cites
- 1928US2002099169A1Tpl-2/cot kinase and methods of useBASF AKTIENGESELLCHAFT·Filed 1999·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →